NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
Clinical trial NCT02721056 · TERMINATED
Trial details
- NCT number
- NCT02721056
- Sponsor
- Nanobiotix
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-28
- Primary completion
- 2020-05-06
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.